🧪
hypothesis

Perturbation-first validation should precede therapeutic claims for Non-Neuronal Transcriptional Changes Preceding Tau Propagation as Early AD Biomarkers

Hypothesis

Perturbation-first validation should precede therapeutic claims for Non-Neuronal Transcriptional Changes Preceding Tau Propagation as Early AD Biomarkers

The debate supports treating this as a validation program before ranking it as a therapy.
🩺 neurodegeneration🎯 Composite 61%💱 $0.56▼8.4%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 1 support 1 oppose
⚠ Missing Evidence⚠ No Target Gene Senate Quality Gates →
Mechanistic 0.63 (15%) Evidence 0.55 (15%) Novelty 0.60 (12%) Feasibility 0.76 (12%) Impact 0.57 (12%) Druggability 0.48 (10%) Safety 0.60 (8%) Competition 0.55 (6%) Data Avail. 0.68 (5%) Reproducible 0.66 (5%) KG Connect 0.50 (8%) 0.608 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite61%

🧪 Overview

The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a proximal molecular phenotype, then a disease-relevant phenotype, in that order.

🧬 Mechanism

🔗 Mechanism from KG

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    APOE__4["APOE ε4"] -->|risk factor for| Alzheimer_s_disease["Alzheimer's disease"]
    APOE__4_1["APOE ε4"] -->|regulates| microglial_lipid_handling["microglial lipid handling"]
    microglial_lipid_handling_2["microglial lipid handling dysfunction"] -->|associated with| Alzheimer_s_disease_progr["Alzheimer's disease progression"]
    non_neuronal_transcriptio["non-neuronal transcriptional changes"] -->|biomarker for| tau_propagation["tau propagation"]
    non_neuronal_cell_types["non-neuronal cell types"] -->|associated with| Alzheimer_s_disease_3["Alzheimer's disease"]
    cell_type_resolution_anal["cell-type resolution analysis"] -->|modulates| causal_subpopulation_effe["causal subpopulation effect detection"]
    bulk_amyloid_readouts["bulk amyloid readouts"] -->|modulates| subpopulation_specific_ef["subpopulation-specific effects"]
    perturbation_experiments["perturbation experiments"] -->|causes| causality_establishment["causality establishment"]
    spatial_transcriptomics_r["spatial transcriptomics resolution"] -->|enables| non_neuronal_dysregulatio["non-neuronal dysregulation pattern detection"]
    APOE__4_driven_microglial["APOE ε4-driven microglial lipid handling"] -->|causes| measurable_proximal_pheno["measurable proximal phenotype"]
    sess_db9a224d_3ebb_429c_8["sess_db9a224d-3ebb-429c-8f02-b703d71ca211_task_66f1207e_recon"] -->|causal extracted| processed["processed"]
    style APOE__4 fill:#ce93d8,stroke:#333,color:#000
    style Alzheimer_s_disease fill:#ef5350,stroke:#333,color:#000
    style APOE__4_1 fill:#ce93d8,stroke:#333,color:#000
    style microglial_lipid_handling fill:#4fc3f7,stroke:#333,color:#000
    style microglial_lipid_handling_2 fill:#4fc3f7,stroke:#333,color:#000
    style Alzheimer_s_disease_progr fill:#ef5350,stroke:#333,color:#000
    style non_neuronal_transcriptio fill:#4fc3f7,stroke:#333,color:#000
    style tau_propagation fill:#4fc3f7,stroke:#333,color:#000
    style non_neuronal_cell_types fill:#4fc3f7,stroke:#333,color:#000
    style Alzheimer_s_disease_3 fill:#ef5350,stroke:#333,color:#000
    style cell_type_resolution_anal fill:#4fc3f7,stroke:#333,color:#000
    style causal_subpopulation_effe fill:#4fc3f7,stroke:#333,color:#000
    style bulk_amyloid_readouts fill:#4fc3f7,stroke:#333,color:#000
    style subpopulation_specific_ef fill:#4fc3f7,stroke:#333,color:#000
    style perturbation_experiments fill:#4fc3f7,stroke:#333,color:#000
    style causality_establishment fill:#4fc3f7,stroke:#333,color:#000
    style spatial_transcriptomics_r fill:#4fc3f7,stroke:#333,color:#000
    style non_neuronal_dysregulatio fill:#4fc3f7,stroke:#333,color:#000
    style APOE__4_driven_microglial fill:#4fc3f7,stroke:#333,color:#000
    style measurable_proximal_pheno fill:#4fc3f7,stroke:#333,color:#000
    style sess_db9a224d_3ebb_429c_8 fill:#4fc3f7,stroke:#333,color:#000
    style processed fill:#4fc3f7,stroke:#333,color:#000

⚖️ Evidence

⚖️ Evidence Matrix1 supports1 contradicts
Supports
The proposed priority experiment is concrete: isogenic APOE3/APOE4 microglia co-cultured with amyloid-bearing neurons, lipidomics, and phagocytosis/degradation assays
Contradicts
Therapeutic tractability is not established by the current source evidence.
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

No DepMap CRISPR Chronos data found for this gene.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.7%
Volatility
Low
0.0016
Events (7d)
3
Price History
▼8.4%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

View on SciDEX ↗